Why Pfizer's Post-COVID Future Looks Brighter Than Ever

finance.yahoo.com/news/why-pfizers-post-covid-future-172800014.html

Key Points
-
Sales of Pfizer's COVID-19 products have collapsed.
-
Thanks to heavy investment fueled by COVID-related revenue, Pfizer has a big pipeline of new potential blockbuster drugs.
-
Cancer treatments Pfizer acquired from Seagen in 2023 are driving growth.
It's been a rough few…

This story appeared on finance.yahoo.com, 2025-09-28 17:28:00.
The Entire Business World on a Single Page. Free to Use →